The Safety and Efficacy of Anticancer Therapy in Breast Cancer Patients with Liver Cirrhosis
It is safe for BC patients with compensated cirrhosis to accept surgery. But they are vulnerable to AEs, disruptions and death during chemotherapy and have poor prognosis. Multidisciplinary cooperation before therapy and closely monitoring AEs during therapy are critical. Attention should be given to optimize the prognosis of special BC patients.
Authors
- Teng Yuan (ORCID: https://orcid.org/0000-0003-1114-7895)
- Chen-Meng Long
- Ren-Bin Liu
- Zhanyi Li (ORCID: https://orcid.org/0000-0001-8068-2010)
- Yu Liu (ORCID: https://orcid.org/0000-0002-6681-2293)
Institutions
- Sun Yat-sen University (CN)
- Liuzhou Maternal and Child Health Hospital (CN)
- Guangzhou Women and Children Medical Center (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/cmar.s503109
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Basic and Applied Basic Research Foundation of Guangdong Province